Navigation Links
UD hosts conference on knowledge-based partnerships Nov. 2

Chad Holliday, chairman and chief executive officer of DuPont, and Abby Joseph Cohen, partner and chief U.S. investment strategist with Goldman Sachs & Co., will be featured speakers at a University of Delaware conference, Creating Knowledge-Based Partnerships: Challenges and Opportunities, to be held Friday, Nov. 2, in Clayton Hall, on the Laird Campus in Newark, Del.

The conference is the first in a new series of programs designed to engage University, government and business leaders in the challenges and opportunities for partnership and to highlight opportunities for enhanced future partnerships. The conference will consider issues in corporate governance, alternative energy, life sciences, the environment, agriculture and advanced materials in a series of panel discussions.

Since I came to Delaware, I have been impressed by the opportunities for partnerships among higher education, business and government at all levels, UD President Patrick Harker said. I look forward to strengthening the University's contribution to such partnerships.

With global competition, knowledge-based partnerships will play an increasingly important role in the advancement of the state, and the nation, throughout the 21st century, he said. This conference is an important first step in identifying Delaware's strengths and in laying the groundwork for increased partnerships between the state's academic institutions, government and the private sector.

The daylong conference will include a welcome by Delaware Gov. Ruth Ann Minner, a morning talk by Holliday on Rising Above the Gathering Storm: Energizing and Employing America for a Brighter Economic Future and luncheon remarks by Cohen.

Several business, government and educational leaders will participate in panel discussions. Respondents to the keynote speech and participants in panel discussions will include U.S. Sen. Tom Carper (D-Del.); Rep. Mike Castle (R-Del.); Jack Markell, Delaware State treasurer; Terry Kelly, CEO of W.L. Gore & Associates; Alan Levin, chairman of the Delaware State Chamber of Commerce; and Barbara Alving, director of the National Institutes of Health National Center for Research Resources. Several University of Delaware faculty members also will be participating.

For the complete schedule, visit [].


Contact: Martin Mbugua
University of Delaware

Related biology news :

1. CO2 sensing proves critical for fungal pathogens to adapt to life in air and human hosts
2. Parasitic plants sniff out hosts
Post Your Comments:
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ), ... has closed the sale of its global contrast media ... Euronext) in a transaction valued at approximately $270 million. ... a total of approximately 1,000 employees spread across the ... Louis area. This entire workforce and the ...
(Date:11/27/2015)... PUNE, India , November 27, 2015 ... --> Growing popularity of companion ... emerging in cancer biomarkers market with pharmaceutical ... develop in-demand companion diagnostic tests. ... --> Complete report on global ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
Breaking Biology Technology: